Marco Gerlinger, The Institute of Cancer Research, Genetic complexity of drug resistance evolution: implications for clinical predictions and therapy in GI and renal cancers

Schedule Sep 12, 2014 Genetic complexity of drug resistance evolution: implications for clinical predictions and therapy in GI and renal cancers Marco Gerlinger, The Institute of Cancer Research